Delivery Order SPE2DB20D1004-SPE2DB23FG1Y3
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $4,994.14 firm-fixed-price delivery order (SPE2DB20D3111|SPE2DB23FB0EB) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4562215936 Latuda 40 mg tablets. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., which was awarded by the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This is a $2,526.46 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 40mg Latuda tablets. The contract, which has no set-aside designation, has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering this medication to support the healthcare needs of military treatment facilities, veterans' hospitals, and other federal healthcare providers. This award is...
- This is a $8,663.90 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of LATUDA 40 MG TABLET 30S, a pharmaceutical product. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a broad range of pharmaceutical and medical supply products to support military...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $23,964.25 contract is for the supply of Latuda 80 mg tablets to support federal healthcare programs. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
- This is a firm fixed price delivery order award to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of Latuda 40 mg tablets to support military treatment programs and facilities. The delivery order has a ceiling value of $1,741.82 and a period of performance through March 18, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and government contractor. The contract, valued at $1,389.44, is for the delivery of the prescription medication Latuda 40 mg tablet in quantities of 30. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Latuda 80 mg tablets. The order has a total ceiling value of $1,143.52 and an ultimate completion date of September 15, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,188.91, is for the supply of 4,567,983,932 units of the prescription medication Latuda 40 mg tablets. The contract has an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania, is delivering these pharmaceutical products to...
- This is a $4,652.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LATUDA 120 MG TABLET 30S, a pharmaceutical product. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,773.99 firm fixed-price contract is for the delivery of Latuda 120 mg tablets. It is not associated with any set-aside designation. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FG1Y3Delivery Order
This is a $9,596.49 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Latuda 40 mg tablets and has a period of performance through July 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies for military healthcare programs globally. This delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen plays a critical role in supplying medical products to federal government agencies, including the DLA and the Department of Justice Federal Bureau of Investigation, through its extensive supply chain and distribution capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 7/7/23 |